Maria Feola, PhD

Excited to share our recent publication @jclinicalinvest on a novel class of small molecule compounds targeting Plek2-Akt interaction to treat #MPN. jci.org/articles/view/…. The diagram summarizes it all.

Thanks to @FierceBiotech for the feature on our strategic collaboration with Primera Therapeutics. @Cellectis is thrilled to be co-developing a mitochondrial DNA toolbox, as we work together to enable effective therapies for mitochondrial diseases. bit.ly/3icYYTv

JUST IN: Elon Musk announced that he will be reinstating the Twitter account of former President Donald Trump. abcn.ws/3TQsM59

Throughout the week, we have highlighted what it means to #InnovateWithCellectis🧬, providing an inside look at the way gene editing can revolutionize treatments: by curing the roots of disease. Thank you for joining us and stay tuned for more innovation and announcements!

New publication from Maria Feola, Yelena Ginsburg, et al: Pleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleation pubmed.ncbi.nlm.nih.gov/33941818/ @pulce86 @BravoCorderoLab @CommsBio @IcahnMountSinai

At @cellectis , our success and innovation are shaped by our most valuable assets – our employees. In honor of #EmployeeAppreciationDay, we would like to thank our incredible employees for embodying our core values of #dedication, #teamwork, #equality, and #ingenuity every day.

Insightful article in @NatureComms, “TALENs emerging as the superior genome-editing tool with editing efficiencies up to 5-fold greater than that of Cas9 in heterochromatin regions.” Thanks to @Illinois_Alma and @CarnegieMellon. Check it out! go.nature.com/36hDjk1

Mark Frattini MD, Ph.D., SVP, Clinical Sciences at @cellectis will participate in a virtual panel hosted by #OCTS tomorrow December 15th at 9AM EST. Dr. Frattini will discuss @cellectis’ preliminary BALLI-01 data that came out at #ASH20. To register: bit.ly/383WhKJ

“My wish is that this will provide a positive message to the young girls who would like to follow the path of science, and to show them that women in science can also have an impact through the research that they are performing.” - 2020 Chemistry Laureate Emmanuelle Charpentier

.@jordanklepper went to another Trump rally and HOLY S**T:

Congratulations! Genome editing is important to advancing the field of #hematology & we want to thank these two great #WomenInScience.

BREAKING NEWS: The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”

Congratulations to Dr. Emmanuelle Charpentier & Dr. Jennifer Doudna for winning The #NobelPrize in Chemistry! This is a major achievement for the field of #geneediting. @cellectis is proud to be part of this adventure! on.wsj.com/2GK5C0w #genetics #biotechnology #CRISPR

@realDonaldTrump It’s beyond irresponsible for the President of the United States to use his one experience with COVID-19 and extrapolate that to millions of people who are suffering. More than 200,000 Americans have already died. Many more are in peril and have every reason to take precautions.

@realDonaldTrump Don’t be afraid of Covid? Not every American has access to the top therapeutics and doctors with the most advanced equipment available to the President of the United States. You feel better than you did 20 years ago? That’s because of your dexamethasone high that resembles mania.

@drsangeetmd @TischCancer @LeukemiaMDA @MDAndersonNews 👏 👏 👏 👏 👏 👏 👏

Miss (my)Sinai(ID),Nyc,loved ones,colleagues 😘...not in any particular order...My badge holder says it all...its been a blast and always will be a blast!! Pun intended. @TischCancer to @LeukemiaMDA @MDAndersonNews Off to Houston from NYC ...#leusm

instagram.com/tv/B-hTgytJ8SS… #COVID19